Alma is launching a new women’s treatment for Alma Duo™. This new treatment protocol uses focused low-intensity extracorporeal shock wave therapy (LI-ESWT) to stimulate blood flow and help increase pleasure for women.
Alma Duo, which is available in North America, was launched in January 2021, having been clinically validated to improve blood flow and bring spontaneity back to men’s lives.
LI-ESWT was introduced in the 1970s for stone fragmentation and has since evolved to successfully address additional medical concerns in orthopedics and in cardiology. It is associated with anti-inflammatory and angiogenic effects. This patented shock wave therapy causes mechanical stress to the treatment site, triggering a cascade of wound healing responses that stimulate blood flow, restore function and support intimacy for women. Alma Duo is a quick, comfortable in-office treatment that requires no topical anesthetic and no downtime.
“People often don’t realize the significant role proper function plays, but when women struggle with intimacy, the effects can be comprehensive. It can negatively affect stress levels, physical health, and strain partner relationships,” says Carolyn DeLucia, MD, an OB/GYN and pioneer of non-invasive sexual wellness treatments. “Alma Duo has been able to reinvigorate this aspect of my patients’ lives, by helping increase their pleasure, comfort and overall interest.”
“We launched Alma Duo to restore natural function, a need shared by millions of men,” says Keith Adams, President of Alma, North America. “With the Alma Duo women’s treatment, we are excited to bring the therapeutic benefits of this second-to-none shock wave technology to a new, and often underserved, patient population.”
